PAS
NVRO

Point72 Asia (Singapore)’s NEVRO CORP. NVRO Stock Holding History

Point72 Asia (Singapore)’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,114
Closed -$95.7K – 1291
2024
Q3 		$95.7K Buy
17,114
+16,889
+7,506% +$118K 0.02% 555
2024
Q2 		$1.9K Sell
225
-6,338
-97% -$67.6K ﹤0.01% 995
2024
Q1 		$94.8K Buy
+6,563
New +$109K 0.02% 655

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Point72 Asia (Singapore)'s NVRO Position: Q4 2024 in Review

Point72 Asia (Singapore) sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 17,114 shares — an estimated $95.7K sold.

Point72 Asia (Singapore) first reported a position in NVRO in Q1 2024 and held it in 3 quarters. The position peaked at $95.7K in Q3 2024. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Point72 Asia (Singapore) reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 17,114 NEVRO CORP. shares in Q4 2024, an estimated $95.7K.
  • Point72 Asia (Singapore) first reported a position in NEVRO CORP. in Q1 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s NEVRO CORP. position peaked at $95.7K in Q3 2024.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q4 2024, filed 14 Feb 2025.